NEW YORK (GenomeWeb) – OncoDNA said today that a number of private health insurers, including BUPA Global Insurance, will now reimburse for its OncoStrat&Go testing in the United Kingdom.

OncoStrat&Go is a combined liquid biopsy and tissue test intended to provide a complete genetic profile of a patient's tumor to predict response to targeted, immunotherapeutic, and chemotherapy treatments.

BUPA Global has created a specific code for the reimbursement of the test, while other UK insurers will use a generic code, OncoDNA said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.